Trial Profile
A Phase I Single-blind, Randomised, Placebo-controlled, Single-centre Study to Investigate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Oral AZD4721 Solution After Single Ascending Doses, and to Compare the Oral Bioavailability of Single Doses of Solution and Suspension in Healthy Subjects
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 08 Jan 2016
Price :
$35
*
At a glance
- Drugs RIST 4721 (Primary)
- Indications Chronic obstructive pulmonary disease
- Focus Adverse reactions
- Sponsors AstraZeneca
- 27 Jan 2014 Status changed from recruiting to completed as reported by Clinicaltrials.gov record.
- 06 Dec 2013 New trial record